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Let’s Be Realistic, Reasonable, and Rational*Y. Chandrashekhar, MD,y Leslee J. Shaw, MD, PHD,z Jagat Narula, MD, PHDxC ardiovascular imaging modalities such ascomputed tomography (CT) and nuclearcardiology procedures have a wealth of evi-
dence on their effectiveness but also expose a patient
to ionizing radiation. Clinical decision making must
therefore balance the beneﬁts of incremental diag-
nostic information with the projected risk after radia-
tion exposure. Therein lies the nub of the problem:
Despite numerous guidelines and research papers,
we still do not have a good measure of the risks of
radiation associated with current-day imaging for an
individual patient.
High-dose radiation has clearly documented
detrimental effects; however, the magnitude of risk
in conventional medical imaging (i.e., low-dose ra-
diation [LDR]) is still a controversial subject. Risk
models span a spectrum from the linear no-threshold
model, wherein any amount of radiation exposure
is considered harmful on the basis of epidemiological
data projected from survivors of high-dose radiation,
to the hormesis model in which LDR might even be
protective. Stochastic effects, such as lasting muta-
tions in DNA and cancer risk, are the main concern,
but they are not immediately obvious, might take
a long time to express, and are likely affected by in-
dividual variation in susceptibility and robustness
of compensatory repair mechanisms.
All our risk estimates for LDR are, at best, pro-
jections, which reﬂect our lack of robust causal*Editorials published in JACC: Cardiovascular Imaging reﬂect the views
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relevant to the contents of this paper to disclose.evidence that radiation exposure from a cardiovas-
cular imaging procedure might result in cancer. Pro-
cedural exposure from CT and nuclear imaging
commonly has effective doses in the range of 5 to <20
mSv, doses equated to LDR, and there is an intense
effort to reduce it further. There are really no clear
and convincing data that radiation below 50 mSv is
associated with cancer in adults (1), and carcinogenic
risk data have been conﬂicting for the exposure
of <100 mSv (2,3). The world of cardiovascular med-
icine is full of probability statements regarding sur-
gical or other therapeutic risk estimates, so much so
that we may often fail to recognize the importance of
the term projected, because it means, in this case, that
direct causal evidence is lacking. Because carcino-
genic risk cannot be assessed by epidemiological
methods alone, proving a direct link between radia-
tion exposure and cancer will require tremendously
large sample sizes (4) and detailed longitudinal da-
tabases to track thousands of patients over decades of
complex care. And we do not have anything even
close to go by.
A biomarker that is sensitive to a gradient of radi-
ation damage could act as a dosimeter and would add
important perspective to risk. Several approaches
have been used to identify surrogates for radiation
risk (2,5). Ionizing radiation often causes DNA dam-
age through double-strand breaks (DSB) that are not
repaired or are repaired badly, ending in oncogenic
chromosomal mutations. Radiation damage also in-
vokes a set of DNA damage responses that involve
checkpoint modiﬁcation and activation of repair
mechanisms, and should they fail, they induce
apoptotic machinery. Visualizing such changes can
serve as a biomarker for radiation-induced DNA
damage (e.g., phosphorylated histones, such as
gH2AX). The lymphocyte is one of the most sensitive
organs affected by radiation, and these cells are
often used as a proxy. Chromosomal damage that
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886could mediate tumorigenesis (6) has been linked
with effective doses of ionizing radiation <50 mSv,
doses common for cardiovascular imaging. However,
there is wide variation in response to radiation-
induced DNA damage or repair (7), which limits
how much it can inform us about the clinical out-
comes of such DNA damage, and these measure-
ments do not tell us anything about the cumulative
effects.SEE PAGE 873In this issue of iJACC, Nguyen et al. (8) furthered
this evidence by examining lymphocytic genetic
biomarkers after radiation exposure from diagnostic
coronary CT angiography in 67 patients. Median
DNA damage was increased by 3.4%, registered as a
change in phosphorylation of any DNA damage
marker, and median apoptosis increased 3.1 times
post-radiation; the absolute magnitude of affected
cells was, however, small. Genetic pathways in-
volved in DNA repair regulation (DDB2, linked to
ultraviolet light exposure and skin cancer risk), DNA
DSB regulation (XRCC4), and apoptosis regulation
(BAX) were activated. These data are not unex-
pected but represent some of the most compre-
hensive data available about the near-term adverse
consequences of exposure to ionizing radiation from
medical imaging. The authors also found that most
cells were successfully repaired by endogenous
repair mechanisms, consistent with the fact that
DSB repair is extremely efﬁcient. It might thus
not be absolutely correct to equate these cellular
changes as cancer surrogates, because we do not
know how much DNA damage is needed to sustain a
stochastic effect. In fact, there is even evidence
that LDR might stimulate reparative mechanisms
that would make cells more resistant to further
damage (9). Nguyen et al. (8) also found a dose
dependency in radiation-induced DNA damage
response, and a mixture of scanner technology
allowed them to study a wide range of effective
doses. The mean total effective dose was 36.9 mSv,
far greater than anything we would use currently
and many fold higher than what is possible in the
future (10). Even within the National Institutes of
Health–National Heart, Lung, and Blood Institute–
sponsored PROMISE (Prospective Multicenter Imag-
ing Study for Evaluation of Chest Pain) trial, cu-
mulative 90-day effective doses were, on average,
in the range of 10 to 14 mSv (11). This becomes
important because the relationship with DSB may be
linear within a range of radiation doses from 1 mGy
to 1 Gy (12). In the present study, DNA damage was
more often identiﬁed in patients with higher bloodradiation doses (w40 mSv vs. 23 mSv for those
without damage, p < 0.0001). Interestingly, no DNA
damage was observed in patients undergoing CT
angiography with a dual-source scanner at an
effective dose of <7 mSv. Among radiation risk
models, one less known model, the linear-threshold
model, assumes a linear range but also a level of
radiation below which there is minimal risk of
cancer (4,13). This formulation does not exclude
some cellular injury, especially one that can be
measured with sensitive biomarkers such as in the
current study, but adequate repair mechanisms may
mitigate obvious stochastic effects. The paper by
Nguyen et al. (8) did not ﬁnd DNA damage or
apoptosis below 7 mSv radiation, whereas both of
these cellular effects increased with increasing dose
beyond that threshold. If this is true, it might shed
some light on the possibility of a linear threshold in
cardiac imaging even in terms of sensitive assays
for DNA damage. This is consistent with other
emerging evidence that tissue damage after radia-
tion may indeed have dose thresholds (14). With
increasing attention to imaging wisely and newer
CT machines bringing down radiation to the sub-1
mSv to 5 mSv range, the fear of radiation may
be far outweighed by the beneﬁts of thoughtful
imaging.
This report by Nguyen et al. (8) is not the deﬁni-
tive study, but despite many limitations, it adds
credence to the importance of optimization of radi-
ation dose reduction in everyday laboratory practice
for CT. Future studies may show what could possibly
be a safe harbor radiation level. The PROMISE
trial showed that CT, as a diagnostic modality, was
associated with similar clinical outcomes compared
with functional imaging with stress electrocardio-
graphy, echocardiography, or myocardial perfusion
imaging (11). Coupled with optimized dose reduction
and appropriate test selection, the evidence has
become quite compelling that CT should be sup-
ported as an important tool for diagnosis of car-
diovascular disease. Having said that, it is also
important to consider this report by Nguyen et al. (8)
as preliminary, and one should not read far too
much into the safe threshold in this study. Use of
radiation principles such as image gently, image
wisely and as low as reasonably achievable (ALARA)
must still remain the cornerstone of good practice.
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